Recent Drug Development Research for January 2025
Plunkett's Health Care Industry Almanac 2022: Health Care Industry Market Research, Statistics, Trends and Leading Companies
Topics: Drug Development, Stem Cell, Hospitals & Clinics, Urgent Care Centers , Telemedicine, EMR (Electronic Medical Record), Health, Medicare & Medicaid, Market Research, Generics Drugs, Regulation & Policy
Regions: Global
| Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Drugs in Development, 2021
Topics: Enzymes, Drug Development, Drug Discovery
| Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| 20s Proteasome - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Drugs in Development, 2021
Topics: Drug Development, AIDS, HIV & STDs, Drug Discovery
| Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Diabetic Foot Ulcers (Metabolic Disorder) - Drugs in Development, 2021
Topics: Drug Development, Diabetes, Drug Discovery
| Diabetic Neuropathy (Metabolic Disorder) - Drugs in Development, 2021
Topics: Drug Development, Diabetes, Drug Discovery
| Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorder) - Drugs in Development, 2021
Topics: Drug Development, Diabetes, Drug Discovery, Endocrinology/Metabolics
| Type 2 Diabetes (Metabolic Disorder) - Drugs in Development, 2021
Topics: Drug Development, Diabetes, Drug Discovery
| Hypercholesterolemia (Metabolic Disorder) - Drugs in Development, 2021
Topics: Drug Development, Diabetes, Hypertension, Drug Discovery, Cardiovascular, Endocrinology/Metabolics
| Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorder) - Drugs in Development, 2021
Topics: Drug Development, Diabetes, Drug Discovery
| Psoriatic Arthritis (Musculoskeletal) - Drugs in Development, 2021
Topics: Drug Development, Arthritis, Drug Discovery
| Muscular Dystrophy (Musculoskeletal) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology
| Ewing Sarcoma (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology
| Anaplastic Astrocytoma (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology
| Gliosarcoma (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Oncology/Hematology
| Pontine Glioma (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, CNS/Neurology, Oncology/Hematology
| Cervical Cancer (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
Regions: Global
| Hepatitis C Virus Envelope Protein E2 - Drugs in Development, 2021
Topics: Drug Development, Hepatitis, Drug Discovery
| Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Drugs in Development, 2021
Topics: Drug Development, Diabetes, Drug Discovery
| Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology
| Hematopoietic Stem Cell Transplantation (Immunology) - Drugs in Development, 2021
Topics: Drug Development, Stem Cell, Blood Supply, Tissue Banking, Transplantation, Drug Discovery
| Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Prescription Drugs, Drug Discovery
| Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Prescription Drugs, Drug Discovery
| Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Prescription Drugs, Drug Discovery
| Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Drugs in Development, 2021
Topics: Drug Development, Stem Cell, Research & Development, Drug Discovery
| P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Drug Discovery
| Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology, Renal
| Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Fatigue Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Restless Legs Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Hyperalgesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Venous Leg Ulcers (Crural ulcer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Nasopharyngitis (Common Cold) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Respiratory/Pulmonary
Regions: Global
| Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, CNS/Neurology
Regions: Global
| Nocturia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
Regions: Global
| Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Clinical Trial
| Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Toll Like Receptor 3 (CD283 or TLR3) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Toll Like Receptor 8 (CD288 or TLR8) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
|
Prev | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
